Similarly, hematological markers such as the neutrophil-to-lymphocyte ratio (NLR) and carcinoembryonic antigen (CEA) have been validated as prognostic indicators in both resectable and advanced CRC [21,22]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.